| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 4,994 | 6,271 | 6,789 | 10,742 | | Selling General and Administrative | 2,638 | 2,622 | 2,603 | 1,794 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,632) | (8,893) | (9,392) | (12,536) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | (3) | 54 | (22) | | Earnings Before Interest And Taxes | (7,631) | (8,896) | (9,338) | (12,558) | | Interest Expense | 519 | 496 | 500 | 491 | | Income Before Tax | (8,150) | (9,392) | (9,838) | (13,049) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,150) | (9,392) | (9,838) | (13,049) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,150) | (9,392) | (9,838) | (13,049) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,150) | ($9,392) | ($9,838) | ($13,049) |
|
0.14% Nasdaq 
0.14%
Income Statement
